References
- Leuner C, Dressman D. (2000). Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Sci, 50:47–60.
- Valizadeh H, Nokhodchi A, Qarakhani N, Zakeri-Milani P, Azarmi S, Hassanzadeh D, . (2004). Physicochemical characterization of solid dispersions of indomethacin with PEG 6000, Myrj 52, Lactose, Sorbitol, Dextrin, and Eudragit® E100. Drug Dev Ind Pharm, 30:303–17.
- Valizadeh H, Zakeri-Milani P, Barzegar-Jalali M, Mohammadi G, Danesh-Bahreini MA, Adibkia, K, . (2007). Preparation and characterization of solid dispersions of piroxicam with hydrophilic carriers. Drug Dev Ind Pharm, 33:45–56.
- Law D, Krill SL, Schmitt EA, Fort JJ, Qiu Y, Wang W, . (2001). Physicochemical considerations in the preparation of amorphous ritonavir–poly(ethylene glycol) 8000 solid dispersions. J Pharm Sci, 90:1015–25.
- Law D, Schmitt EA, Marsh KC, Everitt EA, Wang W, Fort JJ, . (2001). Ritonavir—PEG 8000 amorphous solid dispersions: in vitro and in vivo evaluations. J Pharm Sci, 93:563–70.
- Dannenfelser R, He H, Joshi Y, Bateman S, Serajuddin ATM. (2004). Development of clinical dosage forms for a poorly water soluble drug I: Application of polyethylene glycol–polysorbate 80 solid dispersion carrier system. J Pharm Sci, 93:165–1175.
- Di Martino P, Scoppa M, Joiris E, Palmieri GF, Andres C, Pourcelot Y, . (2001). The spray drying of acetazolamide as method to modify crystal properties and to improve compression behaviour. Int J Pharm, 213:209–21.
- Berggren J, Frenning G, Alderborn G. (2004). Compression behaviour and tablet-forming ability of spray-dried amorphous composite particles. Eur J Pharm Sci, 22:191–200.
- Fichtner F, Mahlin D, Welch K, Gaisford S, Alderborn G. (2008). Effect of surface energy on powder compactibility. Pharm Res, 25:2750–9.
- Curatolo WJ, Herbig SM, Nightingale JAS. (1998). Solid pharmaceutical dispersions with enhanced solubility. European Patent 0 901 786 B1.
- Tanno F, Nishiyama Y, Kokubo H, Obara S. (2004). Evaluation of hypromellose acetate succinate (HPMCAS) as a carrier in solid dispersions. Drug Dev Ind Pharm, 30:9–17.
- Jain S. (1999). Mechanical properties of powders for compaction and tableting: An overview. Pharm Sci Tech Today, 2:20–31.
- Fell JT, Newton JM (1968). The tensile strength of lactose tablets J Pharm Pharmacol, 20:657–8.
- Nokhodchi A, Rubinstein MH, Larhrib H, Guyot JC. (1995). The effect of moisture on the energies involved in the compaction of ibuprofen. Int J Pharm, 120:13–20.
- Heckel RW. (1961a). Density-pressure relationships in powder compaction. Trans Metall Soc AIME, 221:671–5.
- Heckel RW. (1961b). An anlaysis of powder compaction phenomena. Trans Metall Soc AIME, 221:1001–8.
- Roberts RJ, Rowe RC. (1985). The effect of punch velocity on the compaction of a variety of materials. J Pharm Pharmacol, 37:377–84.
- Millqvist-Fureby A, Malmsten M, Bergenstahl B. (1999). Spray-drying of trypsin—Surface characterisation and activity preservation. Int J Pharm, 188:243–53.
- Van der Voort Maarschalk K, Zuurman K, Vromans H, Bolhuis GK, Lerk CF. (1996). Porosity expansion of tablets as a result of bonding and deformation of particulate solids. Int J Pharm, 140:185–93.
- Garr JSM, Rubinstein MH. (1991). An investigation into the capping of paracetamol at increasing speeds of compression. Int J Pharm, 72:117–22.